Anterogen Company
2000
FOUNDED
PUBLIC
STATUS
41-50
EMPLOYEES
065660
STOCK SYMBOL
$32.63
SHARE PRICE
(As of Wednesday Closing)
Description
Anterogen Co Ltd is a bio-venture company engaged in the research and development of cell therapy products and orphan drugs using adult stem cells. Its products include Cupistem injection, Queen cell, Remodulin injection, and TheraStem-Derma. The company also offers cell banking services and analysis services that include sample analysis for clinical studies.
Primary Industry
Biotechnology
Other Industries
Other Pharmaceuticals and Biotechnology
Stock Exchange
KRX
Primary Office
- Namsung Plaza, Gasan-dong
- 405, 130, Digital-ro, Geumcheon-gu
- Seoul, 153-782
- South Korea
+82 0000000000
Request full access to PitchBook
You’re viewing a free company profile from the PitchBook Platform. To explore Anterogen Company’s full profile, request a free trial.
Anterogen Company Stock Performance
| 52 wk Range | Market Cap | Prev. Close | EPS | Average Volume | Shares |
|---|---|---|---|---|---|
| $24.54 - $93.94 | $282M | $29.21 | -$0.16 | 88.6K | 8.65M |
Anterogen Company Financials Summary
|
In Thousands,
USD |
TTM
31-Mar-2019
|
FY 2018
31-Dec-2018
|
FY 2017
31-Dec-2017
|
FY 2016
31-Dec-2016
|
|---|---|---|---|---|
| Enterprise Value | 592,959 | 519,095 | 319,928 | 122,938 |
| Revenue | 3,193 | 3,282 | 4,724 | 4,202 |
| EBITDA | (145) | 538 | 501 | 336 |
| Net Income | (1,365) | (875) | 394 | 319 |
| Total Assets | 105,315 | 90,710 | 54,404 | 29,317 |
| Total Debt | 26,382 | 26,372 | 8,723 |
Public Fundamental Data provided by Morningstar, Inc.
disclaimer
Anterogen Company Valuation and Funding
| Deal Type | Date | Amount | Post-Val | Valuation/ EBITDA |
Debt | Status |
|---|
This information is reserved for PitchBook Platform users. To explore Anterogen Company‘s full profile, request access.
Request full access to PitchBookAnterogen Company Investors
| Investor Name | Investor Type | Holding | Participating Rounds | Investor Since | Board Seat | Contact Info |
|---|
This information is reserved for PitchBook Platform users. To explore Anterogen Company‘s full profile, request access.
Request full access to PitchBookAnterogen Company Executive Team (2)
| Name | Title | Board Seat |
Contact Info |
|---|---|---|---|
| Ike Wan Lee Ph.D | Chief Scientific Officer & Founder |
1 Former Executive
You’re viewing 1 of 2 executives. Get the full list »